Kirsten Bibbins-Domingo
Editor in Chief, JAMA & JAMA Network @jama.com jama.com
Professor, Epidemiology & Biostatistics and Medicine, UCSF profiles.ucsf.edu/kirsten.bibbins-domingo
scientist-physician-teacher
views are my own
- Wishing all a happy and healthy 2026!
- Terrific audience & discussion today @stanforddeptmed.bsky.social Grand Rounds! Thanks for the invitation to speak about Trust in Medical Publishing @jama.com
- Today!
- Join the author of "The Formula for Better Health" on Thurs. Oct 30th at Book Passage — the Bay Area's liveliest bookstore — when @drtomfrieden.bsky.social will be in conversation with JAMA editor @kbibbinsdomingo.bsky.social: www.bookpassage.com/event/tom-fr... #IndieBookstore
- Reposted by Kirsten Bibbins-DomingoJoin the author of "The Formula for Better Health" on Thurs. Oct 30th at Book Passage — the Bay Area's liveliest bookstore — when @drtomfrieden.bsky.social will be in conversation with JAMA editor @kbibbinsdomingo.bsky.social: www.bookpassage.com/event/tom-fr... #IndieBookstore
- Beijing!
- Reposted by Kirsten Bibbins-Domingo📌 Attend "Innovation and Integration in Cardiovascular Medicine" session at #ESCongress 2025, joint session with JAMA and @jamacardiology.com. 🗓️ Monday, September 1 at 8:15 AM. ➡️ Zagreb - Hall 10 ✅ Featuring JAMA editors @kbibbinsdomingo.bsky.social and Greg Curfman.
- Reposted by Kirsten Bibbins-Domingo
- Reposted by Kirsten Bibbins-DomingoDr. Barbara Casadei has been appointed as the next Editor in Chief of JAMA Cardiology. As the Head of the @imperialnhli.bsky.social & @thebhf.bsky.social Prof. of Cardiovascular Medicine, Dr. Casadei is a pioneer in heart failure & atrial fibrillation research. ja.ma/4lPzFl9 #ESCCongress
- Yes!! JAMA Cardiology joins JAMA & other JAMA Network journals on Bluesky! Just in time for #ESCCongress @jamacardiology.com @jama.com @jamanetworkopen.com #MedSky
- Lovely night in Chicago
- Unforgettable afternoon at Stern Grove with the incomparable Diana Ross!
- Thank you to #1 son for making it happen!
- Please to write this @washingtonpost.com Op-Ed with Eric Rubin about the importance of independent medical journals like ours @nejm.org & @jama.com wapo.st/4kUqfV9
- Reposted by Kirsten Bibbins-DomingoExperts from six leading journals are joining us at RISE @ ESC Congress 2025! Gain invaluable insights on crafting high-impact scientific papers, from structure to strategy. 📅 Aug 28, Madrid 🇪🇸 Register now: rise.womenasone.org #LetsRISE2025 #ESCCongress #WCCardio #CardioSky
- Wonderful tribute to a dear colleague- well worth the read www.ucsf.edu/news/2025/06...
- How awesome is this?! JAMA Network Open @jamanetworkopen.com - an open access journal in the JAMA Network - is now on BlueSky! #MedSky
- JAMA Health Forum @jamahealthforum.bsky.social - the health policy journal of the JAMA Network - is now on BlueSky!! #MedSky #ARM25
- Pleasure to meet leaders of the Rwanda Journal of Medicine and Health Sciences- Prof Jansen, EiC, Prof Njunwa, Deputy EiC, & Mr Nisingizwe, Managing Editor JAMA is proud to participate in the African Journal Partnership Program ajpp-online.org
- JAMA Internal Medicine is now on BlueSky! @jamainternalmed.bsky.social #MedSky
- Mothers Day workout ☺️
- Fortunate to still be learning from my trail blazing mom! Happy Mother’s Day!
- No greater source of joy and pride than being “Mom” to this guy…. Send him birthday wishes today! 🎉 🎊
- Celebrating the successful conclusion of another JAMA Week! 🎉 Proud to work alongside this committed team of editors, publishers, staff, board members, & advisors united in the mission of advancing the health of patients & the public through the dissemination of science @jama.com
- Great meeting with the team at JAMA Network Open!!
- The JAMA Network Open editorial team met in person in Chicago this week with JAMA editor @kbibbinsdomingo.bsky.social Great discussions and a beautiful day! @jama.com
- Reposted by Kirsten Bibbins-DomingoAuthors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomized trials to ensure that trial reports are clear and transparent. Learn more in this Special Communication. ja.ma/3Yyu0Hh
- Happy #WomensDay2025 Just a few of the fabulous women I have the good fortune to work with @jama.com & the JAMA Network
- Len Syme, beloved UC Berkeley professor and ‘father of social epidemiology,’ dies at 92 www.sfchronicle.com/bayarea/arti...
- Reposted by Kirsten Bibbins-DomingoThe PRC10 abstract submission site is now open! Abstracts that report new research & findings w generalizable results that can improve scientific research will be given priority. Submit by Jan 31, 2025 at abstracts.peerreviewcongress.org Learn more at peerreviewcongress.org @jama.com @bmj.com
- Remembering President Jimmy Carter with the 2 @JAMA_current editorials he authored- Closing the Gap: The Burden of Unnecessary Illness (9/13/1985) Physicians and Human Rights (5/23/1986)
- Closing the Gap: The Burden of Unnecessary Illness (9/13/1985) jamanetwork.com/journals/jam... Physicians and Human Rights (5/23/1986) jamanetwork.com/journals/jam...
- Reposted by Kirsten Bibbins-DomingoFollow the JAMA Network on WhatsApp to see the latest research across our 13 journals, right where you get all your other news and communications. Share studies from our Network with your network. ja.ma/3Bh6WEM
- Good start to the day!
- Reposted by Kirsten Bibbins-Domingo#AHA24 attendees, check out these key findings from today's JAMA Cardiology presentations 🫀 Partial cardiac denervation effectively reduced the occurrence of postoperative atrial fibrillation after isolated CABG without additional postoperative complications. ➡️ ja.ma/3Z93Iw2
- Excellent JAMA session on AI-enabled digital biomarkers #AHA24 @rohankhera.bsky.social Thanks @ahascience.bsky.social for an excellent meeting & congrats to organizers @dramitkhera.bsky.social & Jo Chikwe
- We had a great session yesterday on AI & Medicine at #AHA24 Join us this morning for: AI-enabled Digital Biomarkers for Enhancing Cardiovascular Disease Prediction and Management: A JAMA Session, 9:45-11:00 AM in S102D
- We had a great session yesterday on AI & Medicine at #AHA24 Join us this morning for: AI-enabled Digital Biomarkers for Enhancing Cardiovascular Disease Prediction and Management: A JAMA Session, 9:45-11:00 AM in S102D
- Reposted by Kirsten Bibbins-DomingoDespite similar performance at the population level, different coronary heart disease polygenic risk scores produced highly variable individual-level risk estimates. #AHA24 ja.ma/3YTigyp
- Reposted by Kirsten Bibbins-DomingoIn this JAMA Cardiology study, zero gravity reduced pulmonary artery diastolic pressure in patients with obesity and HFpEF. ➡️ ja.ma/3USasf6 Stay tuned for more updates from #AHA24! @ahascience.bsky.social
- Sarah Hull, a cardiologist and clinical ethicist, discusses appropriate boundaries for the use of AI in clinical settings. #CardioSky ja.ma/3YNPf7j Listen to the interview here ja.ma/3UPWieH
- JAMA Deputy Editors Linda Brubaker and Preeti Malani give a summary of articles published in JAMA from November 9-15. #MedSky ja.ma/48TSC1p
- Presented today at #AHA24 & simultaneously published in JAMA Cardiology Small mean treatment effects in heart failure trials may still lead to clinically meaningful improvements for a significant proportion of patients. #AHA24 ja.ma/3UOU52T
- Editor's Note: Interpreting Health Status Measures in Patients With Heart Failure—What Counts #AHA24 #CardioSky ja.ma/3AJLrMq
- Welcome to BlueSky @jamacurrent.bsky.social !! Looking forward to seeing old friends & new at #AHA24 #CardioSky #MedSky
- Today in JAMA Analysis of US prescription data (2013-2023) revealed a significant increase in the use of PrEP for HIV prevention. Despite recent availability of oral antivirals and injectable cabotegravir, their uptake remains low. ja.ma/3ACjsy8
- Today in JAMA Artemisinin resistance, linked to K13 protein variants, found in Ugandan children with complicated malaria. Suboptimal efficacy observed for standard artesunate-based treatment. ja.ma/40QXpPb
- Philip Rosenthal provided the accompanying editorial Artemisinin Partial Resistance and the Treatment of Severe Malaria jamanetwork.com/journals/jam...
- Today in JAMA Study found significant rate increases for alcohol-induced liver disease-related hospitalizations and liver transplants across sex and age groups between 2005 and 2021. ja.ma/3CrEoIQ
- Top viewed today at JAMA In this Viewpoint, Sadiya Khan, Chiadi Ndumele, and Dhruv Kazi discuss the clinical, policy, and equity implications of discontinuing glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy. ja.ma/3CroQF1
- Top viewed this week at JAMA CAR T-cell therapy has demonstrated efficacy in treating hematologic malignancies & improving overall survival for patients w/ large B-cell lymphoma. This Review describes approved indications, clinical outcomes, and emerging applications for solid tumors ja.ma/4fnIos2
- Today in JAMA RCT: Initiating tenofovir disoproxil fumarate at 16 weeks' gestation in pregnant women with high HBV DNA levels, combined with infant HBV vaccination, was noninferior to standard care in preventing mother-to-child transmission of HBV. ja.ma/4fGgiIs
- Reposted by Kirsten Bibbins-DomingoIn a new paper lead by Ben Schlüter, we estimated about *1.2 million* youth (<18y) in the US have lost a parent due to drugs or guns since 1999. In 2020, drugs and guns accounted for about one in four parental deaths — about double the proportion in 1999. jamanetwork.com/journals/jam...
- “…one more piece in a growing collection of evidence suggesting that there is no clinical benefit & possibly harm associated with use of supplemental O2 to achieve O2 saturation of the blood beyond 90% to 93%” Richard Schwartzstein A Top Viewed this week ja.ma/49YU6qC
- Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial #medsky …Top Viewed this week at JAMA ja.ma/3TqSuik